Arcadia Biosciences (RKDA) Short Interest Ratio & Short Volume $4.28 +0.09 (+2.03%) Closing price 03:59 PM EasternExtended Trading$4.33 +0.05 (+1.26%) As of 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Arcadia Biosciences Short Interest DataArcadia Biosciences (RKDA) has a short interest of 23,000 shares, representing 1.69% of the float (the number of shares available for trading by the public). This marks a 3.14% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 16,257 shares to cover all short positions.Current Short Interest23,000 sharesPrevious Short Interest22,300 sharesChange Vs. Previous Month+3.14%Dollar Volume Sold Short$99.13 thousandShort Interest Ratio1.4 Days to CoverLast Record DateJune 30, 2025Outstanding Shares1,370,000 sharesFloat Size1,360,000 sharesShort Percent of Float1.69%Today's Trading Volume12,918 sharesAverage Trading Volume16,257 sharesToday's Volume Vs. Average79% Short Selling Arcadia Biosciences? Sign up to receive the latest short interest report for Arcadia Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRKDA Short Interest Over TimeRKDA Days to Cover Over TimeRKDA Percentage of Float Shorted Over Time Arcadia Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202523,000 shares $99.13 thousand +3.1%1.7%1.4 $4.31 6/15/202522,300 shares $110.39 thousand +67.7%1.6%1.8 $4.95 5/31/202513,300 shares $62.51 thousand -31.1%1.0%1.1 $4.70 5/15/202519,300 shares $74.69 thousand +58.2%1.4%1.9 $3.87 4/30/202512,200 shares $42.70 thousand -7.6%0.9%1.4 $3.50 4/15/202513,200 shares $39.20 thousand -1.5%1.0%1.8 $2.97 3/31/202513,400 shares $38.00 thousand +30.1%1.0%1.6 $2.84 3/15/202510,300 shares $34.24 thousand -16.9%0.8%0.7 $3.32 2/28/202512,400 shares $48.48 thousand -17.3%0.9%0 $3.91 2/15/202515,000 shares $72.15 thousand +102.7%1.1%0 $4.81 Get the Latest News and Ratings for RKDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcadia Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20257,400 shares $35.82 thousand -45.6%0.6%0 $4.84 1/15/202513,600 shares $69.63 thousand -68.8%1.0%0 $5.12 12/31/202443,600 shares $258.11 thousand -62.5%3.2%0 $5.92 12/15/2024116,100 shares $731.43 thousand +1,175.8%8.5%0.1 $6.30 11/30/20249,100 shares $25.39 thousand -53.6%0.7%0 $2.79 11/15/202419,600 shares $56.84 thousand -21.3%1.4%1.4 $2.90 10/31/202424,900 shares $96.11 thousand +43.1%4.1%1.9 $3.86 10/15/202417,400 shares $49.07 thousand -19.4%2.8%1.6 $2.82 9/30/202421,600 shares $58.97 thousand -17.2%3.5%2.7 $2.73 9/15/202426,100 shares $72.82 thousand -13.3%4.3%3 $2.79 8/31/202430,100 shares $93.53 thousand +1.4%4.9%3.5 $3.11 8/15/202429,700 shares $82.27 thousand -29.8%4.9%2.9 $2.77 7/31/202442,300 shares $115.48 thousand -24.5%7.1%1.8 $2.73 7/15/202456,000 shares $171.08 thousand -1.4%9.3%2.4 $3.06 6/30/202456,800 shares $178.92 thousand -9.4%9.5%2.2 $3.15 6/15/202462,700 shares $198.64 thousand -13.3%10.4%2.3 $3.17 5/31/202472,300 shares $221.24 thousand +1,264.2%12.0%2.4 $3.06 5/15/20245,300 shares $15.48 thousand -50.5%0.9%0.2 $2.92 4/30/202410,700 shares $21.94 thousand +161.0%1.8%0.5 $2.05 4/15/20244,100 shares $7.75 thousand +10.8%0.7%0.2 $1.89 3/31/20243,700 shares $8.18 thousand No Change0.6%0.2 $2.21 3/15/20243,700 shares $9.44 thousand -9.8%0.6%0.1 $2.55 2/29/20244,100 shares $11.69 thousand +51.9%0.7%0.1 $2.85 2/15/20242,700 shares $7.97 thousand +80.0%0.5%0.1 $2.95 1/31/20241,500 shares $3.59 thousand -91.0%0.3%0 $2.39 1/15/202416,600 shares $43.99 thousand +97.6%2.8%0.5 $2.65 12/31/20238,400 shares $26.29 thousand -19.2%1.4%0.2 $3.13 12/15/202310,400 shares $30.37 thousand +82.5%1.7%0.5 $2.92 11/30/20235,700 shares $16.53 thousand +18.8%1.0%0.3 $2.90 11/15/20234,800 shares $14.78 thousand -52.9%0.8%0.3 $3.08This tiny loophole could hand you massive winners… (Ad)Top institutions are raising their year-end targets for one of the biggest assets out there… Several weeks ago, Standard Chartered’s Head of Digital Assets revised his target for Q2 2025 from $120k… openly acknowledging $200K is in play. And with the kind of momentum we’ve seen from this top asset - Bitcoin - in recent weeks, I wouldn’t be surprised if it hits that target in the coming months. In fact, from what I’m seeing, the stars are aligned for a bull run… and its next leg up could be just around the corner.Just tap this link and you’ll be all set. 10/31/202310,200 shares $34.97 thousand +100.0%1.7%0.6 $3.43 10/15/20235,100 shares $16.01 thousand -8.9%0.9%0.3 $3.14 9/30/20235,600 shares $18.76 thousand +33.3%0.9%0.2 $3.35 9/15/20234,200 shares $15.41 thousand +600.0%0.7%0.1 $3.67 8/31/2023600 shares $2.10 thousand -87.2%0.1%0 $3.50 8/15/20234,700 shares $20.54 thousand -57.7%0.8%0.1 $4.37 7/31/202311,100 shares $49.06 thousand -33.1%1.9%0.3 $4.42 7/15/202316,600 shares $74.04 thousand +44.4%2.8%0.3 $4.46 6/30/202311,500 shares $44.62 thousand +29.2%1.9%0.3 $3.88 6/15/20238,900 shares $37.02 thousand -29.9%1.5%0.3 $4.16 5/31/202312,700 shares $58.29 thousand +2.4%2.2%0.4 $4.59 5/15/202312,400 shares $61.01 thousand -69.8%2.1%0.1 $4.92 4/30/202341,000 shares $250.10 thousand -1.9%6.9%0.3 $6.10 4/15/202341,800 shares $278.81 thousand +1.0%7.1%0.3 $6.67 3/31/202341,400 shares $309.26 thousand -42.8%7.1%0.3 $7.47 3/15/202372,400 shares $528.52 thousand +2,684.6%12.3%0.5 $7.30 2/28/20232,600 shares $650.26 -97.5%0.4%0 $0.25 2/15/2023102,700 shares $27.73 thousand +13.5%N/A0.4 $0.27 1/31/202390,500 shares $23.50 thousand -23.1%N/A0.4 $0.26 1/15/2023117,700 shares $42.36 thousand +16.3%N/A0.6 $0.36 12/30/2022101,200 shares $27.43 thousand -63.2%N/A0.5 $0.27 12/15/2022274,900 shares $87.91 thousand -38.1%N/A1.5 $0.32 11/30/2022443,800 shares $148.76 thousand -28.7%N/A2.4 $0.34 11/15/2022622,500 shares $208.29 thousand +83.6%N/A3.1 $0.33 10/31/2022339,000 shares $142.72 thousand -10.9%N/A1.7 $0.42 10/15/2022380,400 shares $154.59 thousand -6.7%N/A2.3 $0.41 9/30/2022407,800 shares $215.28 thousand -3.0%N/A2.7 $0.53 9/15/2022420,200 shares $322.71 thousand -12.0%N/A2.7 $0.77 8/31/2022477,500 shares $416.62 thousand -10.1%N/A2.9 $0.87 8/15/2022531,400 shares $526.09 thousand +14.6%N/A2.9 $0.99 7/31/2022463,800 shares $388.66 thousand -1.9%2.2%1.4 $0.84 7/15/2022472,700 shares $466.79 thousand +13.3%2.3%1.3 $0.99 6/30/2022417,400 shares $417.40 thousand -29.6%2.0%0.9 $1.00 6/15/2022592,900 shares $610.69 thousand -16.8%2.8%0.7 $1.03 5/31/2022712,600 shares $976.26 thousand +9.7%3.4%0.3 $1.37 5/15/2022649,600 shares $656.10 thousand -14.6%3.1%0.3 $1.01 4/30/2022760,900 shares $734.27 thousand -25.4%3.6%0.3 $0.97 4/15/20221,020,000 shares $1.09 million -19.1%4.9%0.5 $1.07 3/31/20221,260,000 shares $1.76 million -58.4%6.0%0.5 $1.40 3/15/20223,030,000 shares $4.51 million +311.7%14.4%1.3 $1.49 2/28/2022735,900 shares $732.22 thousand -23.1%3.5%0.6 $1.00 2/15/2022956,900 shares $995.18 thousand -8.0%4.6%1 $1.04 1/31/20221,040,000 shares $908.96 thousand -9.6%5.1%1.1 $0.87 1/15/20221,150,000 shares $1.18 million +30.7%5.7%1.1 $1.03 12/31/2021880,100 shares $915.30 thousand +8.8%4.3%1 $1.04 12/15/2021809,000 shares $809 thousand -5.7%4.0%2.4 $1.00 11/30/2021857,700 shares $1.11 million -19.1%4.2%2.8 $1.29 11/15/20211,060,000 shares $2.18 million +6.9%5.2%3.4 $2.06 10/29/2021991,600 shares $1.93 million +11.1%4.9%3.3 $1.95 10/15/2021892,200 shares $1.81 million -8.2%4.4%3.6 $2.03This tiny loophole could hand you massive winners… (Ad)Top institutions are raising their year-end targets for one of the biggest assets out there… Several weeks ago, Standard Chartered’s Head of Digital Assets revised his target for Q2 2025 from $120k… openly acknowledging $200K is in play. And with the kind of momentum we’ve seen from this top asset - Bitcoin - in recent weeks, I wouldn’t be surprised if it hits that target in the coming months. In fact, from what I’m seeing, the stars are aligned for a bull run… and its next leg up could be just around the corner.Just tap this link and you’ll be all set. 9/30/2021971,600 shares $2.01 million -30.1%4.8%3.3 $2.07 9/15/20211,390,000 shares $2.99 million -2.8%6.8%4.1 $2.15 8/31/20211,430,000 shares $3.46 million +7.5%7.1%2.9 $2.42 8/13/20211,330,000 shares $3.13 million +7.3%6.6%2.3 $2.35 7/30/20211,240,000 shares $2.91 million -4.6%6.4%2 $2.35 7/15/20211,300,000 shares $3.43 million +13.0%6.7%1.5 $2.64 6/30/20211,150,000 shares $3.42 million +13.9%5.9%1.3 $2.97 6/15/20211,010,000 shares $2.75 million -9.8%5.2%0.4 $2.72 5/28/20211,120,000 shares $3.17 million -15.8%5.7%0.5 $2.83 5/14/20211,330,000 shares $3.15 million -2.2%N/A0.6 $2.37 4/30/20211,360,000 shares $3.67 million -19.1%N/A0.4 $2.70 4/15/20211,680,000 shares $4.25 million +40.0%N/A0.6 $2.53 3/31/20211,200,000 shares $2.80 million +13.2%N/A0.4 $2.33 3/15/20211,060,000 shares $3.28 million +6.7%N/A0.6 $3.09 2/26/2021993,100 shares $3.16 million -64.9%N/A0.6 $3.18 2/12/20212,830,000 shares $12.99 million +44.4%N/A1.9 $4.59 1/29/20211,960,000 shares $5.64 million +851.9%N/A3.3 $2.88 1/15/2021205,900 shares $580.64 thousand +35.6%N/A0.5 $2.82 12/31/2020151,900 shares $378.23 thousand +56.9%N/A0.5 $2.49 12/15/202096,800 shares $294.27 thousand +39.7%N/A0.4 $3.04 11/30/202069,300 shares $230.61 thousand -65.4%N/A0.3 $3.33 11/15/2020200,300 shares $562.84 thousand -44.5%N/A1 $2.81 10/30/2020361,000 shares $1.12 million -32.8%N/A1.8 $3.09 10/15/2020536,900 shares $1.82 million -1.6%N/A2.6 $3.39 9/30/2020545,600 shares $1.53 million +20.0%N/A2.4 $2.80 9/15/2020454,600 shares $1.39 million -6.1%N/A2.1 $3.06 8/31/2020483,900 shares $1.51 million +10.0%N/A2.3 $3.12 8/14/2020439,800 shares $1.45 million +3.6%N/A2 $3.30 7/31/2020424,400 shares $1.51 million +22.9%N/A1.8 $3.56 RKDA Short Interest - Frequently Asked Questions What is Arcadia Biosciences' current short interest? Short interest is the volume of Arcadia Biosciences shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 23,000 shares of RKDA short. 1.69% of Arcadia Biosciences' shares are currently sold short. Learn More on Arcadia Biosciences' current short interest. What is a good short interest ratio for Arcadia Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RKDA shares currently have a short interest ratio of 1.0. Learn More on Arcadia Biosciences's short interest ratio. What is a good short interest percentage for Arcadia Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.69% of Arcadia Biosciences' floating shares are currently sold short. Is Arcadia Biosciences' short interest increasing or decreasing? Arcadia Biosciences saw a increase in short interest in June. As of June 30th, there was short interest totaling 23,000 shares, an increase of 3.1% from the previous total of 22,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Arcadia Biosciences' float size? Arcadia Biosciences currently has issued a total of 1,370,000 shares. Some of Arcadia Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Arcadia Biosciences currently has a public float of 1,360,000 shares. How does Arcadia Biosciences' short interest compare to its competitors? 1.69% of Arcadia Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Arcadia Biosciences: Nocera, Inc. (0.83%), Origin Agritech Limited (0.36%), S&W Seed Company (2.03%), Inspire Veterinary Partners, Inc. (2.30%), Edible Garden AG Incorporated (1.83%), Shineco (11.69%), African Agriculture Holdings Inc. (4.49%), Corteva, Inc. (1.22%), BrightView Holdings, Inc. (8.23%), Adecoagro S.A. (2.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Arcadia Biosciences stock? Short selling RKDA is an investing strategy that aims to generate trading profit from Arcadia Biosciences as its price is falling. RKDA shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arcadia Biosciences? A short squeeze for Arcadia Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RKDA, which in turn drives the price of the stock up even further. How often is Arcadia Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RKDA, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Nocera Short Interest Data Origin Agritech Short Interest Data S&W Seed Short Interest Data Inspire Veterinary Partners Short Interest Data Edible Garden Short Interest Data Shineco Short Interest Data African Agriculture Short Interest Data African Agriculture Short Interest Data Edible Garden Short Interest Data Yotta Acquisition Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RKDA) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcadia Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcadia Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
